Athens Research/Cambio - Excellence in Molecular Biology/2kU/LR2D1132K

价格
面议
货号:LR2D1132K
浏览量:72
品牌:Athens Research
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Enzymes for Molecular Biology

Enzymes for Molecular Biology: Enzymes for Molecular Biology

  • Catalogue
  • Description
  • Protocols
  • Applications & Benefits

T4 RNA Ligase 2, Deletion Mutant

T4 RNA Ligase 2, Deletion Mutant, also known as T4Rnl2(1-249)

BioSearch Tech (Lucigen/Epicentre)

Catalogue No.DescriptionPack SizePriceQty
  • Change to:
  • €
LR2D11310K T4 RNA Ligase 2, Deletion Mutant10kU£217.00QuantityAdd to Order
LR2D1132KT4 RNA Ligase 2, Deletion Mutant2kU£63.00QuantityAdd to Order

T4 RNA Ligase 2, Deletion Mutant

T4 RNA Ligase 2, Deletion Mutant, also known as T4Rnl2(1-249)

BioSearch Tech (Lucigen/Epicentre)

Ligate single-stranded adenylated DNA or RNA oligos to RNA targets for a variety of applications.

  • Ligate single-stranded adenylated DNA or RNA oligos to RNA targets
  • Use this enzyme to prepare cDNA libraries for small-RNA transcriptome analysis such as RNA-Seq
  • Perform linker ligation for miRNA cloning applications

T4 RNA Ligase 2, Deletion Mutant, also known as T4Rnl2(1-249), is used to ligate single-stranded adenylated DNA or RNA oligonucleotides to small RNAs for cloning or next-generation RNA sequencing. The preadenylated 5´ ends of DNA or RNA are ligated to the 3´ ends of RNA. Unlike the full-length enzyme, T4Rnl2(1-249) is unable to adenylate the 5´ end of the substrate in the presence of ATP. However, it can use a preactivated donor (App-DNA or App-RNA) and join it to the 3´ end of an acceptor; thus, performing the ligation reaction in the absence of ATP which prevents circularization and other undesirable bimolecular reactions.

The enzyme is available in 2,000 and 10,000-Unit sizes at a concentration of 200 U/µl. The enzyme is supplied with a 10X Reaction Buffer.

Unit Definition: One unit is the amount of enzyme required to give 50% ligation of a 22-mer RNA to the preadenylated end of a 17-mer DNA when both oligos are annealed to a complementary 39-mer DNA strand in 30 minutes at 37°C under standard assay conditions.

Storage Buffer: 50% glycerol containing 50 mM Tris-HCl (pH 7.5), 0.1 M NaCl, 0.1 mM EDTA, 1 mM dithiothreitol (DTT), and 0.1% Triton® X-100.

T4 RNA Ligase 2, Deletion Mutant, 10X Reaction Buffer: 500 mM Tris-HCl (pH 7.5), 20 mM MgCl2, and 10 mM DTT.

Activity Assay: The unit definition assay is performed in a reaction containing 50 mM Tris-HCl (pH 7.5), 2 mM MgCl2, 1 mM DTT and 0.4 µg of equimolar mix of 22-mer, 17-mer and 39-mer oligonucleotides, and varying amounts of enzyme.

Quality Control: T4 RNA Ligase 2, Deletion Mutant, is free of detectable DNA exo- and endonuclease, and RNase activities.

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

T4 RNA Ligase 2, Deletion Mutant

T4 RNA Ligase 2, Deletion Mutant, also known as T4Rnl2(1-249)

BioSearch Tech (Lucigen/Epicentre)

PROTOCOL

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

T4 RNA Ligase 2, Deletion Mutant

T4 RNA Ligase 2, Deletion Mutant, also known as T4Rnl2(1-249)

BioSearch Tech (Lucigen/Epicentre)

Applications

  • Preparing cDNA libraries for small-RNA transcriptome analysis such as RNA-Seq.
  • Optimal linker ligation for miRNA cloning.

If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200

Myeloperoxidase Enzyme Immunoassay Kit 髓过氧化物酶 免疫分析试剂盒 Human MPO EIA KIT FEATURES: USE - Measure human MPO in a variety of matrices SAMPLE -Serum, Platelet-Poor Heparin Plasma, Saliva, Urine or Tissue Culture Media SAMPLES / KIT - 40 in duplicate SENSITIVITY - 0.068 ng/mL STABILITY - liquid reagents stable at 4°C QUICK RESULTS - 2.5 HOURS Myeloperoxidase (MPO) is a tetrameric heme-containing protein abundantly produced in neutrophil granulocytes where it plays an important anti-microbial role. During degranulation MPO is released into the extracellular space. There, as part of the neutrophils “respiratory burst”, it produces hypochlorous acid from hydrogen peroxide and Cl–. MPO also uses hydrogen peroxide to oxidize tyrosine to the tyrosyl radical. Both hypochlorous acid and tyrosyl are cytotoxic and when present can kill bacteria and other pathogens. Hereditary deficiency of myeloperoxidase predisposes individuals to immune deficiency. Studies have shown an association between elevated MPO levels and coronary artery disease, and in 2003 it was suggested that MPO may serve as a sensitive predictor of myocardial infarction in patients complaining of chest pain. Since that time the clinical utility of MPO testing in cardiac patients has been solidly established in the literature with well over 100 papers published. In 2010 this clinical application was further refined by additional studies which determined that measuring both MPO and C-reactive protein (CRP) provided more accurate prediction of mortality risk than measuring just CRP alone.